BCSCDB: Biomarkers of Cancer Stem Cells Database
Number of entries related to PK59 cell line is 163
| GENE | HGNC_ID | MARKER_TYPE | CANCER_TYPE | HISTOLOGICAL_TYPE | CELL_LINE | CSC_ENRICHMENT | METHOD | EXPRESSION_LEVEL | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ALDH1A1 | 402 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.32 | 0.684 | 34414448 |
| ALDH1A1 | 402 | LTM | Pancreatic Cancer | Carcinoma | PK59 | NA | ALDEFLUOR assay followed by SFA and qRT-PCR | NA | 0.32 | 0.684 | 34414448 |
| KCNB1 | 6231 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics and qRT-PCR | Up | 0.24 | 0.0011 | 34414448 |
| KCNC1 | 6233 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics and qRT-PCR | Up | 0.24 | 0.0021 | 34414448 |
| KCND1 | 6237 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics and qRT-PCR | Up | 0.24 | 0.0011 | 34414448 |
| CD44 | 1681 | LTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by qRT-PCR | NA | 0.2 | 1 | 34414448 |
| PROM1 | 9454 | LTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.7582 | 34414448 |
| ABCC9 | 60 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 34414448 |
| ADGRL3 | 20974 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 34414448 |
| ADIRF | 24043 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34414448 |
| ADRA1B | 278 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 34414448 |
| ANKS6 | 26724 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34414448 |
| ANXA3 | 541 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0085 | 34414448 |
| ANXA6 | 544 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0053 | 34414448 |
| ANXA8L1 | 23334 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 34414448 |
| ASIC1 | 100 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 34414448 |
| ATCAY | 779 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 34414448 |
| B3GNT3 | 13528 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 34414448 |
| BASP1 | 957 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 34414448 |
| BEX3 | 13388 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 34414448 |
| BNIP3 | 1084 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 34414448 |
| BTBD6 | 19897 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34414448 |
| C11orf96 | 38675 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 34414448 |
| CACNA1A | 1388 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 34414448 |
| CACNA1G | 1394 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 34414448 |
| CACNA1H | 1395 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 34414448 |
| CACNA1I | 1396 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 34414448 |
| CACNA2D1 | 1399 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0064 | 34414448 |
| CACNA2D2 | 1400 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 34414448 |
| CACNB4 | 1404 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 34414448 |
| CACNG4 | 1408 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 34414448 |
| CACNG6 | 13625 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34414448 |
| CBS | 1550 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 34414448 |
| CCL2 | 10618 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0074 | 34414448 |
| CDKN2A | 1787 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34414448 |
| CEACAM6 | 1818 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 34414448 |
| CEACAM7 | 1819 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34414448 |
| CHGB | 1930 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 34414448 |
| CLCA4 | 2018 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 34414448 |
| CLCN3 | 2021 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 34414448 |
| CLCN5 | 2023 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 34414448 |
| CLIC5 | 13517 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34414448 |
| CNGA4 | 2152 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 34414448 |
| CST6 | 2478 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34414448 |
| CTSF | 2531 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 34414448 |
| CXCR4 | 2561 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0498 | 34414448 |
| DNAH14 | 2945 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 34414448 |
| EFEMP1 | 3218 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 34414448 |
| EXO5 | 26115 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 34414448 |
| FA2H | 21197 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 34414448 |
| FAM92A | 30452 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 34414448 |
| FBP1 | 3606 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 34414448 |
| FXYD3 | 4027 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 34414448 |
| GABRD | 4084 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 34414448 |
| GAP43 | 4140 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 34414448 |
| GJC1 | 4280 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 34414448 |
| GJC1 | 4280 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 34414448 |
| GLI1 | 4317 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0308 | 34414448 |
| GNB4 | 20731 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 34414448 |
| GNG11 | 4403 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 34414448 |
| GPM6A | 4460 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 34414448 |
| GRIK2 | 4580 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 34414448 |
| GRIN2A | 4585 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 34414448 |
| GRIN3B | 16768 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 34414448 |
| GRINA | 4589 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 34414448 |
| GSTM3 | 4635 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 34414448 |
| H19 | 4713 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 34414448 |
| HCN1 | 4845 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 34414448 |
| HCN4 | 16882 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 34414448 |
| HDGFL3 | 24937 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 34414448 |
| HGF | 4893 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 34414448 |
| HS6ST2 | 19133 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 34414448 |
| IGFBP7 | 5476 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 34414448 |
| IL1RN | 6000 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 34414448 |
| INPP5D | 6079 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34414448 |
| ITPR1 | 6180 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 34414448 |
| JAM2 | 14686 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 34414448 |
| KCNE2 | 6242 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 34414448 |
| KCNF1 | 6246 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 34414448 |
| KCNG1 | 6248 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 34414448 |
| KCNG3 | 18306 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 34414448 |
| KCNH1 | 6250 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 34414448 |
| KCNK12 | 6274 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 34414448 |
| KCNK13 | 6275 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 34414448 |
| KCNMA1 | 6284 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 34414448 |
| KCNMB3 | 6287 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 34414448 |
| KCNQ1 | 6294 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 34414448 |
| KCNQ2 | 6296 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 34414448 |
| KCNT1 | 18865 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 34414448 |
| KCTD13 | 22234 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 34414448 |
| KCTD4 | 23227 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 34414448 |
| KIRREL2 | 18816 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 34414448 |
| KLK6 | 6367 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 34414448 |
| KLK8 | 6369 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34414448 |
| KRT5 | 6442 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 34414448 |
| KRT6A | 6443 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 34414448 |
| KRT6C | 20406 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 34414448 |
| KRT83 | 6460 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34414448 |
| KRT86 | 6463 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34414448 |
| LAD1 | 6472 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 34414448 |
| LDHB | 6541 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 34414448 |
| LHX2 | 6594 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 34414448 |
| LRRC8C | 25075 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 34414448 |
| LY6D | 13348 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34414448 |
| MAGEA6 | 6804 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 34414448 |
| MAL2 | 13634 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 34414448 |
| MALL | 6818 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 34414448 |
| MAP9 | 26118 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 34414448 |
| MAPK13 | 6875 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 34414448 |
| MCOLN2 | 13357 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 34414448 |
| MCOLN3 | 13358 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 34414448 |
| MGST2 | 7063 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 34414448 |
| MPZL2 | 3496 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 34414448 |
| NETO2 | 14644 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 34414448 |
| OLFML2A | 27270 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 34414448 |
| OVOL1 | 8525 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 34414448 |
| PHGDH | 8923 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 34414448 |
| PKDREJ | 9015 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 34414448 |
| PLAAT1 | 14922 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 34414448 |
| PLAT | 9051 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 34414448 |
| PRAME | 9336 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 34414448 |
| PSAT1 | 19129 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 34414448 |
| PYCARD | 16608 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34414448 |
| RFLNB | 28705 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 34414448 |
| RGS20 | 14600 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 34414448 |
| RNF130 | 18280 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 34414448 |
| RNF182 | 28522 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 34414448 |
| RRBP1 | 10448 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 34414448 |
| RTN1 | 10467 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 34414448 |
| S100P | 10504 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0106 | 34414448 |
| SALL2 | 10526 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 34414448 |
| SCD5 | 21088 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 34414448 |
| SCEL | 10573 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 34414448 |
| SCG2 | 10575 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 34414448 |
| SCN3B | 20665 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 34414448 |
| SCN8A | 10596 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 34414448 |
| SCN9A | 10597 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 34414448 |
| SERPINB1 | 3311 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 34414448 |
| SERPINB5 | 8949 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 34414448 |
| SLC9A1 | 11071 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 34414448 |
| SLPI | 11092 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0074 | 34414448 |
| SOX2 | 11195 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.5695 | 34414448 |
| SOX2 | 11195 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.5695 | 34414448 |
| TACSTD2 | 11530 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 34414448 |
| TCEAL4 | 26121 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 34414448 |
| TCEAL9 | 30084 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 34414448 |
| TFPI2 | 11761 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 34414448 |
| THBD | 11784 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34414448 |
| TIMP3 | 11822 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 34414448 |
| TMEM139 | 22058 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34414448 |
| TMEM150C | 37263 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 34414448 |
| TMEM63C | 23787 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 34414448 |
| TNS4 | 24352 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 34414448 |
| TRIM29 | 17274 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0074 | 34414448 |
| TRPC1 | 12333 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 34414448 |
| TRPM8 | 17961 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 34414448 |
| TRPV2 | 18082 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 34414448 |
| TTYH2 | 13877 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 34414448 |
| TUT4 | 28981 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 34414448 |
| UCA1 | 37126 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 34414448 |
| VEGFC | 12682 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 34414448 |
| WFDC2 | 15939 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 34414448 |
| ZACN | 29504 | HTM | Pancreatic Cancer | Carcinoma | PK59 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 34414448 |